Kiniksa Pharmaceuticals International Plc (KNSA)
41.83
+0.80
(+1.95%)
USD |
NASDAQ |
Jan 21, 16:00
41.85
+0.02
(+0.05%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap: 3.171B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 36.51M |
| NovoCure Ltd. | 1.518B |
| LivaNova Plc | 3.455B |
| ADMA Biologics, Inc. | 4.132B |
| Akanda Corp. | 0.2098M |
Market Cap Related Metrics
| PE Ratio | 93.31 |
| PS Ratio | 5.359 |
| Price to Book Value | 5.922 |
| Price to Free Cash Flow | 31.50 |
| Price | 41.83 |
| Earnings Yield | 1.07% |
| Operating PE Ratio | 83.99 |
| Normalized PE Ratio | 93.31 |